Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397
Status:
Completed
Trial end date:
2012-01-11
Target enrollment:
Participant gender:
Summary
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help
doctors predict how well patients will respond to treatment.
PURPOSE: This research study is studying biomarkers in patients with metastatic or recurrent
head and neck cancer treated with cisplatin and cetuximab on ECOG-E5397.